Investor Woodline Partners LP
13D/G Filings

This page shows a list of all the recent 13D/G filings made by Woodline Partners LP . Schedule 13D is commonly referred to as a “beneficial ownership report.” The term "beneficial owner" is defined under SEC rules. It includes any person who directly or indirectly shares voting power or investment power (the power to sell the security).

When a person or group of persons acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities, they are required to file a Schedule 13D within ten days after the purchase. Click the link icon to see the full transaction history.

Date Form Target Prev
Shares
Current
Shares
Change
(Percent)
Ownership
(Percent)
Change
(Percent)
2025-08-14 13G SGMT / Sagimet Biosciences Inc. 2,552,536
2025-08-14 13G/A TNYA / Tenaya Therapeutics, Inc. 5,916,167 9,000,000
2025-08-14 13G TNGX / Tango Therapeutics, Inc. 6,029,906
2025-08-14 13G AIRO / AIRO Group Holdings, Inc. 1,952,611
2025-08-14 13G/A ALGS / Aligos Therapeutics, Inc. 315,383 518,300
2025-05-15 13G ALGS / Aligos Therapeutics, Inc. 315,383
2025-05-15 13G TNYA / Tenaya Therapeutics, Inc. 5,916,167
2025-05-15 13G OM / Outset Medical, Inc. 1,325,784
2025-02-14 13G/A TVTX / Travere Therapeutics, Inc. 4,340,340 2,114,056
2025-02-14 13G/A GRDN / Guardian Pharmacy Services, Inc. 568,131 415,120
2025-02-14 13G/A TARA / Protara Therapeutics, Inc. 1,576,567 1,331,258
2024-11-14 13G GRDN / Guardian Pharmacy Services, Inc. 568,131
2024-11-14 13G TVTX / Travere Therapeutics, Inc. 4,340,340
2024-11-14 13G ZVRA / Zevra Therapeutics, Inc. 4,048,653
2024-11-14 13G TARA / Protara Therapeutics, Inc. 1,576,567
2024-02-12 13G VERA / Vera Therapeutics, Inc. 1,140,632
2024-02-12 13G/A CLDI / Calidi Biotherapeutics, Inc. 400,000 125,000
2024-02-12 13G/A US6710051060 / OPY Acquisition Corp. I 200,000 0
2023-02-10 13G/A SNTI / Senti Biosciences, Inc. 0
2023-02-10 13G US6710051060 / OPY Acquisition Corp. I 200,000
2023-02-10 13G/A ACDI / Ascendant Digital Acquisition Corp III - Class A 1,912,500 1,286,000
2023-02-10 13G/A CLDI / Calidi Biotherapeutics, Inc. 1,980,000 400,000
2022-02-11 13G DYNS / Dynamics Special Purpose Corp Class A 2,000,000
2022-02-11 13G ACDI / Ascendant Digital Acquisition Corp III - Class A 1,912,500
2022-02-11 13G CLDI / Calidi Biotherapeutics, Inc. 1,980,000
2022-02-11 13G/A MKTW / MarketWise, Inc. 0
2022-02-11 13G/A ELDN / Eledon Pharmaceuticals, Inc. 685,273
2021-02-16 13G/A MKTW / MarketWise, Inc. 4,008,770
2021-02-16 13G 88907J107 / Novus Therapeutics, Inc. 814,756